Results 21 to 30 of about 336,084 (346)

Metastatic basal cell carcinoma – A dramatic case

open access: bronzeCanadian Journal of Plastic Surgery, 2000
Metastatic basal cell carcinoma (MBCC) is extremely rare, with an incidence of 0.0028% to 0.1%. Typical lesions are large, ulcerated, neglected, refractory to treatment and occur more commonly in middle-aged men. Metastases are usually single and to local lymph nodes. Multiple metastases to distant sites are much less common.
Gavin David French, David D Jewer
openalex   +3 more sources

Metastatic basal cell carcinoma of buccal mucosa: a report of a rare case. [PDF]

open access: goldWorld J Surg Oncol, 2022
Kimura T   +7 more
europepmc   +5 more sources

Clinical activity of PD-1 inhibition in the treatment of locally advanced or metastatic basal cell carcinoma. [PDF]

open access: goldJ Immunother Cancer, 2022
In GK   +17 more
europepmc   +3 more sources

Metastatic basal cell carcinoma with loss of p63 and mismatch repair proteins [PDF]

open access: yesJAAD Case Reports, 2017
Nathan M. Johnson, MS   +5 more
doaj   +2 more sources

Basal Cell Carcinoma with Disseminated Bone Metastization: An Unusual Outcome of the Most Common Malignancy

open access: yesRevista da Sociedade Portuguesa de Dermatologia e Venereologia, 2021
Basal cell carcinoma is the most common skin cancer, with a very low incidence of metastases, associated with high morbidity and mortality. The morpheaform clinical variant is uncommon, presenting an aggressive growth pattern.
Luísa Rolim   +6 more
doaj   +1 more source

Metastatic basal cell skin cancer with distant metastatic skeletal lesions: a clinical case report

open access: yesОпухоли головы и шеи, 2023
Clinical cases of distant metastasis of basal cell skin cancer are extremely rarely described in the international publications. This is probably due to the specific locally advanced growth of this histological type of tumor, as well as to the ...
A. P. Polyakov   +2 more
doaj   +1 more source

Atezolizumab for the treatment of advanced recurrent basal cell carcinoma and urothelial carcinoma of bladder: a case report

open access: yesJournal of Medical Case Reports, 2022
Background The use of checkpoint inhibitors has become increasingly important in the treatment of different cancers, including advanced muscle-invasive urothelial cancer and even in basal cell carcinoma.
Zsófia Küronya   +6 more
doaj   +1 more source

Molecular testing in metastatic basal cell carcinoma [PDF]

open access: yesJournal of the American Academy of Dermatology, 2021
Metastatic basal cell carcinoma (mBCC) is a very rare entity, and diagnosis can be challenging. Therapeutic options are limited, and response to targeted therapy is poor.To demonstrate a clonal relationship between BCCs and their metastases and to explore which hedgehog pathway-related mutations are involved in mBCC.Genetic analysis was conducted in 10
Verkouteren, B.J.A.   +11 more
openaire   +4 more sources

Hedgehog signaling pathway and its targets for treatment in basal cell carcinoma [PDF]

open access: yes, 2012
Basal cell carcinoma (BCC) of the skin is the most common type of cancer, and accounts for up to 40% of all cancers in the United States with a growing incidence rate in the last decades in all developed countries.
CUCCHI, DANILO   +3 more
core   +3 more sources

Home - About - Disclaimer - Privacy